Skip to content
340B pharmacy

You don't need to qualify for 340B. Our hospital partners already do.

340B eligibility is held by a covered entity — a hospital that meets HRSA's rules. A private practice does not become 340B-eligible on its own, and no honest company will tell you it can. What we do is connect your practice to a hospital partner that is already a covered entity.

HematologyHematology-oncologyMedical oncologyNephrologyPulmonary diseaseRheumatology
Which hospitals, which markets

The network answers the question you're already asking.

Pennsylvania

Tenor Health Foundation

A nonprofit that acquires and operates community hospitals across Pennsylvania. It runs four hospitals — Sharon Regional, Wilkes-Barre General, Regional Hospital of Scranton, and Moses Taylor Hospital — with a network of 700+ physicians and providers.

Chicago, Illinois

Insight Hospital and Medical Center

A nonprofit safety-net hospital serving Chicago's Bronzeville community. Insight holds URAC Specialty Pharmacy accreditation, which matters directly for high-drug-cost specialty care.

Works with covered entities in both markets

ElevaRx Care Coordination

A care-coordination program that works alongside 340B covered entities to handle medication access, prior authorization, adherence follow-up, and provider communication. The physician prescribes independently; the covered entity dispenses.

Full network and geography
How affiliation actually works

Who is responsible for what.

The hospital (covered entity)

  • Holds 340B eligibility and HRSA registration
  • Owns the patient records the program is built on
  • Dispenses through its 340B pharmacy
  • Retains the 340B savings, lawfully

Your practice

  • Prescribes on medical necessity, exactly as today
  • Provides care and documentation for your patients
  • Keeps full clinical authority
  • Signs the affiliation agreement — and nothing more onerous

What changes in the room

  • Nothing about your clinical judgment
  • Prescriptions route to the covered-entity pharmacy
  • Coordination and follow-up are handled for you
  • Enrollment is voluntary and never changes the prescription
Patient definition, in plain language

340B pricing applies to a patient of the covered entity. In practice that means the hospital partner maintains records of that patient's care — the relationship is real and documented, not a label applied at the pharmacy counter.

This is the most audited element of an arrangement like this one. We cover it openly because a program run properly has nothing to hide here, and because you will read it exactly that way. The covered entity is, and stays, the 340B partner. Your practice never becomes the covered entity.

If any vendor implies your practice itself becomes 340B-eligible, stop the conversation. That is not how the program works, and it is the fastest way into an audit finding.

Compliance infrastructure

Your real fear is an audit, not a missed margin.

So this is built for audit first. Here is what runs underneath the program.

01

Duplicate-discount prevention

We prevent a drug from being counted for both a 340B discount and a Medicaid rebate — the error HRSA looks for first.

02

Diversion controls

340B-purchased drugs go only to eligible patients of the covered entity. We track it so it stays that way.

03

Inventory and split-billing support

Virtual or physical inventory kept clean, with split-billing that survives an audit.

04

Audit readiness

The audit file is built as you go, not assembled in a panic when HRSA calls.

05

HRSA recertification support

Annual recertification is tracked and prepared so eligibility never lapses.

Illustrative math

Start from your annual specialty drug spend.

The precondition is on the same screen as the number, because the number means nothing without it.

Your numbers · editable
$2,000,000
80%
25%

This assumes affiliation with a participating covered entity (our hospital partners). A private practice does not qualify for 340B on its own. Actual pricing is set by manufacturers and HRSA and varies by drug and arrangement.

Illustrative estimate
Spend on 340B-eligible drugs
$1,600,000
Illustrative annual drug-cost reduction
$400,000

Illustrative estimate only. Not a promise of savings.

Check 340B for your practice
Is this you?

If 340B isn't your fit, we'll say so.

Most of your revenue is patient visits?

  • You run a high-volume chronic-care panel
  • Specialty drugs are a small share of revenue
  • You're internal medicine, family practice, cardiology, or endocrinology
Look at RPM instead

Worried about the staff work?

  • You can see the margin but not the bandwidth
  • You don't want to hire for compliance and billing
  • You want to know exactly what gets handled for you
See what we handle